ClinicalTrials.gov
ClinicalTrials.gov Menu

Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00250809
Recruitment Status : Completed
First Posted : November 8, 2005
Last Update Posted : January 7, 2010
Sponsor:
Information provided by:
University of New Mexico

Brief Summary:
CVC Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

Condition or disease Intervention/treatment Phase
Other Female Genital Cancer Procedure: Placement of a central venous catheter Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: CVC Pros and Cons of Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study
Study Start Date : March 1994
Actual Primary Completion Date : December 2005
Actual Study Completion Date : March 2006

Intervention Details:
    Procedure: Placement of a central venous catheter
    Placement of a central venous catheter


Primary Outcome Measures :
  1. Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange [ Time Frame: 3 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

1. Patients who require the placement of a central venous catheter for medical purposes and have an absence of infection.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00250809


Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico

Responsible Party: Harriet Smith, MD; Principal Investigator, University of New Mexico - CRTC
ClinicalTrials.gov Identifier: NCT00250809     History of Changes
Other Study ID Numbers: CVC
First Posted: November 8, 2005    Key Record Dates
Last Update Posted: January 7, 2010
Last Verified: March 2009